Austin, TX 的 第二型糖尿病 臨床試驗
12 項針對 第二型糖尿病 的研究正在 Austin(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
招募中3 期
- Texas Diabetes & Endocrinology, Austin
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Pinnacle Clinical Research - Austin, Austin
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
招募中3 期
- Texas Diabetes and Endocrinology - Central Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- IMA Clinical Research Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Austin
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
招募中2 期
- IMA Clinical Research, Austin
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- Velocity Clinical Research, Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
招募中3 期
- Elligo Clinical Research Center, Austin
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
招募中3 期
- Pinnacle Clinical Research, Austin
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
招募中
- Texas Diabetes & Endocrinology, Austin
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
招募中
- Texas Diabetes and Endocrinology, Austin
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
招募中2 期
- Elligo Health Research, Inc., Austin
其他城市的 第二型糖尿病 試驗
- San Antonio, TX37 項研究
- Houston, TX31 項研究
- Orlando, FL24 項研究
- Boston, MA20 項研究
- Miami, FL19 項研究
- Chicago, IL19 項研究
- Dallas, TX19 項研究
- Columbus, OH18 項研究
- Las Vegas, NV18 項研究
- Atlanta, GA17 項研究
- San Diego, CA17 項研究
- Los Angeles, CA16 項研究
Austin 的其他研究
- 非小細胞肺癌30 項研究
- 癌症(所有類型)20 項研究
- 肥胖症20 項研究
- 轉移性癌症19 項研究
- 大腸直腸癌19 項研究
- 心臟衰竭18 項研究
- 乳癌18 項研究
- 過重18 項研究
- 卵巢癌17 項研究
- 子宮內膜癌15 項研究
- 前列腺癌15 項研究
- 憂鬱症14 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月5日。各研究自行設定資格標準;由研究團隊決定參與者資格。